Pharmaceutical giant Pfizer has agreed to pay $35 million to settle allegations that it unlawfully hindered the sale of Lipitor, a drug prescribed to lower cholesterol, resulting in buyers paying ...

Pfizer lost its patent on the cholesterol-lowering drug Lipitor on November 30 -- which spells big savings for many of the 8.7 million Americans who take the medication. The patent’s expiration ...